nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—HTR2B—Raloxifene—osteoporosis	0.163	0.276	CbGbCtD
Eletriptan—CYP2C9—Estropipate—osteoporosis	0.0521	0.0882	CbGbCtD
Eletriptan—ABCB1—Ethinyl Estradiol—osteoporosis	0.0326	0.0551	CbGbCtD
Eletriptan—CYP2C19—Cholecalciferol—osteoporosis	0.0323	0.0546	CbGbCtD
Eletriptan—CYP3A4—Estropipate—osteoporosis	0.0303	0.0513	CbGbCtD
Eletriptan—CYP3A4—Calcitriol—osteoporosis	0.0303	0.0513	CbGbCtD
Eletriptan—CYP2C9—Cholecalciferol—osteoporosis	0.0268	0.0454	CbGbCtD
Eletriptan—CYP2C19—Estradiol—osteoporosis	0.026	0.044	CbGbCtD
Eletriptan—CYP2D6—Cholecalciferol—osteoporosis	0.0245	0.0415	CbGbCtD
Eletriptan—CYP3A4—Ergocalciferol—osteoporosis	0.0242	0.041	CbGbCtD
Eletriptan—ABCB1—Conjugated Estrogens—osteoporosis	0.0239	0.0405	CbGbCtD
Eletriptan—CYP2C9—Estradiol—osteoporosis	0.0216	0.0366	CbGbCtD
Eletriptan—ABCB1—Estradiol—osteoporosis	0.021	0.0355	CbGbCtD
Eletriptan—CYP3A4—Raloxifene—osteoporosis	0.0202	0.0342	CbGbCtD
Eletriptan—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0195	0.033	CbGbCtD
Eletriptan—CYP3A4—Cholecalciferol—osteoporosis	0.0156	0.0264	CbGbCtD
Eletriptan—CYP3A4—Conjugated Estrogens—osteoporosis	0.0143	0.0242	CbGbCtD
Eletriptan—CYP3A4—Estradiol—osteoporosis	0.0126	0.0213	CbGbCtD
Eletriptan—Insomnia—Risedronate—osteoporosis	0.000209	0.000604	CcSEcCtD
Eletriptan—Anxiety—Zoledronate—osteoporosis	0.000208	0.000603	CcSEcCtD
Eletriptan—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000208	0.000602	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000207	0.000601	CcSEcCtD
Eletriptan—Paraesthesia—Risedronate—osteoporosis	0.000207	0.0006	CcSEcCtD
Eletriptan—Pruritus—Estropipate—osteoporosis	0.000206	0.000598	CcSEcCtD
Eletriptan—Discomfort—Zoledronate—osteoporosis	0.000206	0.000598	CcSEcCtD
Eletriptan—Asthenia—Alendronate—osteoporosis	0.000206	0.000598	CcSEcCtD
Eletriptan—Hypersensitivity—Ibandronate—osteoporosis	0.000206	0.000597	CcSEcCtD
Eletriptan—Cough—Conjugated Estrogens—osteoporosis	0.000206	0.000597	CcSEcCtD
Eletriptan—Dyspnoea—Risedronate—osteoporosis	0.000206	0.000596	CcSEcCtD
Eletriptan—Hypotension—Pamidronate—osteoporosis	0.000205	0.000594	CcSEcCtD
Eletriptan—Convulsion—Conjugated Estrogens—osteoporosis	0.000205	0.000593	CcSEcCtD
Eletriptan—Dry mouth—Zoledronate—osteoporosis	0.000204	0.000592	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000204	0.000592	CcSEcCtD
Eletriptan—Fatigue—Ethinyl Estradiol—osteoporosis	0.000204	0.000591	CcSEcCtD
Eletriptan—Pruritus—Alendronate—osteoporosis	0.000203	0.000589	CcSEcCtD
Eletriptan—Dyspepsia—Risedronate—osteoporosis	0.000203	0.000588	CcSEcCtD
Eletriptan—Tinnitus—Estradiol—osteoporosis	0.000203	0.000587	CcSEcCtD
Eletriptan—Constipation—Ethinyl Estradiol—osteoporosis	0.000202	0.000586	CcSEcCtD
Eletriptan—Confusional state—Zoledronate—osteoporosis	0.000202	0.000585	CcSEcCtD
Eletriptan—Hypersensitivity—Calcitriol—osteoporosis	0.000202	0.000585	CcSEcCtD
Eletriptan—Flushing—Estradiol—osteoporosis	0.000202	0.000584	CcSEcCtD
Eletriptan—Myalgia—Conjugated Estrogens—osteoporosis	0.000201	0.000583	CcSEcCtD
Eletriptan—Arthralgia—Conjugated Estrogens—osteoporosis	0.000201	0.000583	CcSEcCtD
Eletriptan—Asthenia—Ibandronate—osteoporosis	0.000201	0.000582	CcSEcCtD
Eletriptan—Anxiety—Conjugated Estrogens—osteoporosis	0.0002	0.000581	CcSEcCtD
Eletriptan—Nausea—Etidronic acid—osteoporosis	0.0002	0.000581	CcSEcCtD
Eletriptan—Oedema—Zoledronate—osteoporosis	0.0002	0.00058	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.0002	0.000579	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.0002	0.000579	CcSEcCtD
Eletriptan—Diarrhoea—Estropipate—osteoporosis	0.0002	0.000579	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Risedronate—osteoporosis	0.000199	0.000577	CcSEcCtD
Eletriptan—Fatigue—Risedronate—osteoporosis	0.000199	0.000576	CcSEcCtD
Eletriptan—Insomnia—Pamidronate—osteoporosis	0.000198	0.000575	CcSEcCtD
Eletriptan—Pruritus—Ibandronate—osteoporosis	0.000198	0.000574	CcSEcCtD
Eletriptan—Pain—Risedronate—osteoporosis	0.000197	0.000571	CcSEcCtD
Eletriptan—Constipation—Risedronate—osteoporosis	0.000197	0.000571	CcSEcCtD
Eletriptan—Shock—Zoledronate—osteoporosis	0.000197	0.000571	CcSEcCtD
Eletriptan—Paraesthesia—Pamidronate—osteoporosis	0.000197	0.00057	CcSEcCtD
Eletriptan—Diarrhoea—Alendronate—osteoporosis	0.000197	0.00057	CcSEcCtD
Eletriptan—Asthenia—Calcitriol—osteoporosis	0.000197	0.00057	CcSEcCtD
Eletriptan—Nervous system disorder—Zoledronate—osteoporosis	0.000196	0.000569	CcSEcCtD
Eletriptan—Immune system disorder—Estradiol—osteoporosis	0.000196	0.000569	CcSEcCtD
Eletriptan—Dyspnoea—Pamidronate—osteoporosis	0.000195	0.000566	CcSEcCtD
Eletriptan—Tachycardia—Zoledronate—osteoporosis	0.000195	0.000566	CcSEcCtD
Eletriptan—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000195	0.000565	CcSEcCtD
Eletriptan—Chills—Estradiol—osteoporosis	0.000195	0.000565	CcSEcCtD
Eletriptan—Somnolence—Pamidronate—osteoporosis	0.000195	0.000565	CcSEcCtD
Eletriptan—Skin disorder—Zoledronate—osteoporosis	0.000195	0.000564	CcSEcCtD
Eletriptan—Pruritus—Calcitriol—osteoporosis	0.000194	0.000562	CcSEcCtD
Eletriptan—Hyperhidrosis—Zoledronate—osteoporosis	0.000194	0.000561	CcSEcCtD
Eletriptan—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000193	0.00056	CcSEcCtD
Eletriptan—Diarrhoea—Raloxifene—osteoporosis	0.000193	0.00056	CcSEcCtD
Eletriptan—Dyspepsia—Pamidronate—osteoporosis	0.000193	0.000559	CcSEcCtD
Eletriptan—Dizziness—Estropipate—osteoporosis	0.000193	0.000559	CcSEcCtD
Eletriptan—Oedema—Conjugated Estrogens—osteoporosis	0.000193	0.000559	CcSEcCtD
Eletriptan—Alopecia—Estradiol—osteoporosis	0.000192	0.000556	CcSEcCtD
Eletriptan—Diarrhoea—Ibandronate—osteoporosis	0.000191	0.000555	CcSEcCtD
Eletriptan—Anorexia—Zoledronate—osteoporosis	0.000191	0.000553	CcSEcCtD
Eletriptan—Decreased appetite—Pamidronate—osteoporosis	0.000191	0.000552	CcSEcCtD
Eletriptan—Dizziness—Alendronate—osteoporosis	0.00019	0.000551	CcSEcCtD
Eletriptan—Shock—Conjugated Estrogens—osteoporosis	0.00019	0.00055	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000189	0.000548	CcSEcCtD
Eletriptan—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000189	0.000548	CcSEcCtD
Eletriptan—Fatigue—Pamidronate—osteoporosis	0.000189	0.000548	CcSEcCtD
Eletriptan—Gastrointestinal pain—Risedronate—osteoporosis	0.000189	0.000546	CcSEcCtD
Eletriptan—Tachycardia—Conjugated Estrogens—osteoporosis	0.000188	0.000545	CcSEcCtD
Eletriptan—Urticaria—Ethinyl Estradiol—osteoporosis	0.000188	0.000545	CcSEcCtD
Eletriptan—Constipation—Pamidronate—osteoporosis	0.000187	0.000543	CcSEcCtD
Eletriptan—Pain—Pamidronate—osteoporosis	0.000187	0.000543	CcSEcCtD
Eletriptan—Diarrhoea—Calcitriol—osteoporosis	0.000187	0.000543	CcSEcCtD
Eletriptan—Skin disorder—Conjugated Estrogens—osteoporosis	0.000187	0.000543	CcSEcCtD
Eletriptan—Hypotension—Zoledronate—osteoporosis	0.000187	0.000542	CcSEcCtD
Eletriptan—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000187	0.000542	CcSEcCtD
Eletriptan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000187	0.000542	CcSEcCtD
Eletriptan—Dizziness—Raloxifene—osteoporosis	0.000187	0.000542	CcSEcCtD
Eletriptan—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000186	0.00054	CcSEcCtD
Eletriptan—Flatulence—Estradiol—osteoporosis	0.000186	0.00054	CcSEcCtD
Eletriptan—Tension—Estradiol—osteoporosis	0.000186	0.000538	CcSEcCtD
Eletriptan—Vomiting—Estropipate—osteoporosis	0.000186	0.000538	CcSEcCtD
Eletriptan—Dysgeusia—Estradiol—osteoporosis	0.000185	0.000537	CcSEcCtD
Eletriptan—Dizziness—Ibandronate—osteoporosis	0.000185	0.000536	CcSEcCtD
Eletriptan—Rash—Estropipate—osteoporosis	0.000184	0.000533	CcSEcCtD
Eletriptan—Dermatitis—Estropipate—osteoporosis	0.000184	0.000533	CcSEcCtD
Eletriptan—Anorexia—Conjugated Estrogens—osteoporosis	0.000184	0.000533	CcSEcCtD
Eletriptan—Nervousness—Estradiol—osteoporosis	0.000184	0.000532	CcSEcCtD
Eletriptan—Urticaria—Risedronate—osteoporosis	0.000183	0.000531	CcSEcCtD
Eletriptan—Back pain—Estradiol—osteoporosis	0.000183	0.00053	CcSEcCtD
Eletriptan—Headache—Estropipate—osteoporosis	0.000183	0.00053	CcSEcCtD
Eletriptan—Vomiting—Alendronate—osteoporosis	0.000183	0.00053	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000182	0.000529	CcSEcCtD
Eletriptan—Body temperature increased—Risedronate—osteoporosis	0.000182	0.000528	CcSEcCtD
Eletriptan—Abdominal pain—Risedronate—osteoporosis	0.000182	0.000528	CcSEcCtD
Eletriptan—Muscle spasms—Estradiol—osteoporosis	0.000182	0.000527	CcSEcCtD
Eletriptan—Rash—Alendronate—osteoporosis	0.000181	0.000525	CcSEcCtD
Eletriptan—Insomnia—Zoledronate—osteoporosis	0.000181	0.000525	CcSEcCtD
Eletriptan—Dermatitis—Alendronate—osteoporosis	0.000181	0.000525	CcSEcCtD
Eletriptan—Feeling abnormal—Pamidronate—osteoporosis	0.000181	0.000524	CcSEcCtD
Eletriptan—Hypotension—Conjugated Estrogens—osteoporosis	0.00018	0.000522	CcSEcCtD
Eletriptan—Headache—Alendronate—osteoporosis	0.00018	0.000522	CcSEcCtD
Eletriptan—Paraesthesia—Zoledronate—osteoporosis	0.00018	0.000521	CcSEcCtD
Eletriptan—Vomiting—Raloxifene—osteoporosis	0.00018	0.000521	CcSEcCtD
Eletriptan—Gastrointestinal pain—Pamidronate—osteoporosis	0.000179	0.000519	CcSEcCtD
Eletriptan—Dyspnoea—Zoledronate—osteoporosis	0.000179	0.000517	CcSEcCtD
Eletriptan—Rash—Raloxifene—osteoporosis	0.000178	0.000516	CcSEcCtD
Eletriptan—Dermatitis—Raloxifene—osteoporosis	0.000178	0.000516	CcSEcCtD
Eletriptan—Somnolence—Zoledronate—osteoporosis	0.000178	0.000516	CcSEcCtD
Eletriptan—Vomiting—Ibandronate—osteoporosis	0.000178	0.000516	CcSEcCtD
Eletriptan—Tremor—Estradiol—osteoporosis	0.000177	0.000513	CcSEcCtD
Eletriptan—Headache—Raloxifene—osteoporosis	0.000177	0.000513	CcSEcCtD
Eletriptan—Rash—Ibandronate—osteoporosis	0.000176	0.000511	CcSEcCtD
Eletriptan—Dermatitis—Ibandronate—osteoporosis	0.000176	0.000511	CcSEcCtD
Eletriptan—Dyspepsia—Zoledronate—osteoporosis	0.000176	0.000511	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000176	0.000509	CcSEcCtD
Eletriptan—Ill-defined disorder—Estradiol—osteoporosis	0.000175	0.000508	CcSEcCtD
Eletriptan—Headache—Ibandronate—osteoporosis	0.000175	0.000508	CcSEcCtD
Eletriptan—Insomnia—Conjugated Estrogens—osteoporosis	0.000174	0.000505	CcSEcCtD
Eletriptan—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000174	0.000505	CcSEcCtD
Eletriptan—Vomiting—Calcitriol—osteoporosis	0.000174	0.000505	CcSEcCtD
Eletriptan—Decreased appetite—Zoledronate—osteoporosis	0.000174	0.000504	CcSEcCtD
Eletriptan—Agitation—Estradiol—osteoporosis	0.000174	0.000504	CcSEcCtD
Eletriptan—Nausea—Estropipate—osteoporosis	0.000173	0.000502	CcSEcCtD
Eletriptan—Body temperature increased—Pamidronate—osteoporosis	0.000173	0.000502	CcSEcCtD
Eletriptan—Abdominal pain—Pamidronate—osteoporosis	0.000173	0.000502	CcSEcCtD
Eletriptan—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000173	0.000502	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000173	0.000501	CcSEcCtD
Eletriptan—Angioedema—Estradiol—osteoporosis	0.000173	0.000501	CcSEcCtD
Eletriptan—Rash—Calcitriol—osteoporosis	0.000173	0.000501	CcSEcCtD
Eletriptan—Fatigue—Zoledronate—osteoporosis	0.000173	0.0005	CcSEcCtD
Eletriptan—Dermatitis—Calcitriol—osteoporosis	0.000173	0.0005	CcSEcCtD
Eletriptan—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000172	0.000498	CcSEcCtD
Eletriptan—Headache—Calcitriol—osteoporosis	0.000172	0.000497	CcSEcCtD
Eletriptan—Somnolence—Conjugated Estrogens—osteoporosis	0.000171	0.000497	CcSEcCtD
Eletriptan—Pain—Zoledronate—osteoporosis	0.000171	0.000496	CcSEcCtD
Eletriptan—Constipation—Zoledronate—osteoporosis	0.000171	0.000496	CcSEcCtD
Eletriptan—Nausea—Alendronate—osteoporosis	0.000171	0.000495	CcSEcCtD
Eletriptan—Malaise—Estradiol—osteoporosis	0.000171	0.000494	CcSEcCtD
Eletriptan—Hypersensitivity—Risedronate—osteoporosis	0.00017	0.000492	CcSEcCtD
Eletriptan—Vertigo—Estradiol—osteoporosis	0.00017	0.000492	CcSEcCtD
Eletriptan—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00017	0.000492	CcSEcCtD
Eletriptan—Asthenia—Ethinyl Estradiol—osteoporosis	0.00017	0.000492	CcSEcCtD
Eletriptan—Syncope—Estradiol—osteoporosis	0.00017	0.000491	CcSEcCtD
Eletriptan—Nausea—Raloxifene—osteoporosis	0.000168	0.000487	CcSEcCtD
Eletriptan—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000168	0.000486	CcSEcCtD
Eletriptan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000167	0.000485	CcSEcCtD
Eletriptan—Palpitations—Estradiol—osteoporosis	0.000167	0.000484	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000166	0.000482	CcSEcCtD
Eletriptan—Fatigue—Conjugated Estrogens—osteoporosis	0.000166	0.000482	CcSEcCtD
Eletriptan—Nausea—Ibandronate—osteoporosis	0.000166	0.000482	CcSEcCtD
Eletriptan—Loss of consciousness—Estradiol—osteoporosis	0.000166	0.000482	CcSEcCtD
Eletriptan—Asthenia—Risedronate—osteoporosis	0.000165	0.000479	CcSEcCtD
Eletriptan—Feeling abnormal—Zoledronate—osteoporosis	0.000165	0.000478	CcSEcCtD
Eletriptan—Cough—Estradiol—osteoporosis	0.000165	0.000478	CcSEcCtD
Eletriptan—Pain—Conjugated Estrogens—osteoporosis	0.000165	0.000478	CcSEcCtD
Eletriptan—Constipation—Conjugated Estrogens—osteoporosis	0.000165	0.000478	CcSEcCtD
Eletriptan—Gastrointestinal pain—Zoledronate—osteoporosis	0.000164	0.000475	CcSEcCtD
Eletriptan—Hypertension—Estradiol—osteoporosis	0.000163	0.000473	CcSEcCtD
Eletriptan—Pruritus—Risedronate—osteoporosis	0.000163	0.000473	CcSEcCtD
Eletriptan—Nausea—Calcitriol—osteoporosis	0.000163	0.000472	CcSEcCtD
Eletriptan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000162	0.000469	CcSEcCtD
Eletriptan—Hypersensitivity—Pamidronate—osteoporosis	0.000162	0.000468	CcSEcCtD
Eletriptan—Arthralgia—Estradiol—osteoporosis	0.000161	0.000466	CcSEcCtD
Eletriptan—Myalgia—Estradiol—osteoporosis	0.000161	0.000466	CcSEcCtD
Eletriptan—Anxiety—Estradiol—osteoporosis	0.00016	0.000465	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00016	0.000463	CcSEcCtD
Eletriptan—Urticaria—Zoledronate—osteoporosis	0.000159	0.000461	CcSEcCtD
Eletriptan—Discomfort—Estradiol—osteoporosis	0.000159	0.000461	CcSEcCtD
Eletriptan—Body temperature increased—Zoledronate—osteoporosis	0.000158	0.000459	CcSEcCtD
Eletriptan—Abdominal pain—Zoledronate—osteoporosis	0.000158	0.000459	CcSEcCtD
Eletriptan—Diarrhoea—Risedronate—osteoporosis	0.000158	0.000457	CcSEcCtD
Eletriptan—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000158	0.000457	CcSEcCtD
Eletriptan—Dry mouth—Estradiol—osteoporosis	0.000157	0.000456	CcSEcCtD
Eletriptan—Asthenia—Pamidronate—osteoporosis	0.000157	0.000456	CcSEcCtD
Eletriptan—Dizziness—Ethinyl Estradiol—osteoporosis	0.000156	0.000453	CcSEcCtD
Eletriptan—Confusional state—Estradiol—osteoporosis	0.000156	0.000451	CcSEcCtD
Eletriptan—Pruritus—Pamidronate—osteoporosis	0.000155	0.000449	CcSEcCtD
Eletriptan—Oedema—Estradiol—osteoporosis	0.000154	0.000447	CcSEcCtD
Eletriptan—Urticaria—Conjugated Estrogens—osteoporosis	0.000153	0.000444	CcSEcCtD
Eletriptan—Dizziness—Risedronate—osteoporosis	0.000153	0.000442	CcSEcCtD
Eletriptan—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000152	0.000442	CcSEcCtD
Eletriptan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000152	0.000442	CcSEcCtD
Eletriptan—Shock—Estradiol—osteoporosis	0.000152	0.00044	CcSEcCtD
Eletriptan—Nervous system disorder—Estradiol—osteoporosis	0.000151	0.000439	CcSEcCtD
Eletriptan—Tachycardia—Estradiol—osteoporosis	0.000151	0.000436	CcSEcCtD
Eletriptan—Vomiting—Ethinyl Estradiol—osteoporosis	0.00015	0.000436	CcSEcCtD
Eletriptan—Diarrhoea—Pamidronate—osteoporosis	0.00015	0.000435	CcSEcCtD
Eletriptan—Skin disorder—Estradiol—osteoporosis	0.00015	0.000434	CcSEcCtD
Eletriptan—Hyperhidrosis—Estradiol—osteoporosis	0.000149	0.000432	CcSEcCtD
Eletriptan—Rash—Ethinyl Estradiol—osteoporosis	0.000149	0.000432	CcSEcCtD
Eletriptan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000149	0.000432	CcSEcCtD
Eletriptan—Headache—Ethinyl Estradiol—osteoporosis	0.000148	0.000429	CcSEcCtD
Eletriptan—Hypersensitivity—Zoledronate—osteoporosis	0.000148	0.000428	CcSEcCtD
Eletriptan—Vomiting—Risedronate—osteoporosis	0.000147	0.000425	CcSEcCtD
Eletriptan—Rash—Risedronate—osteoporosis	0.000145	0.000421	CcSEcCtD
Eletriptan—Dermatitis—Risedronate—osteoporosis	0.000145	0.000421	CcSEcCtD
Eletriptan—Dizziness—Pamidronate—osteoporosis	0.000145	0.00042	CcSEcCtD
Eletriptan—Headache—Risedronate—osteoporosis	0.000144	0.000419	CcSEcCtD
Eletriptan—Asthenia—Zoledronate—osteoporosis	0.000144	0.000416	CcSEcCtD
Eletriptan—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000142	0.000412	CcSEcCtD
Eletriptan—Pruritus—Zoledronate—osteoporosis	0.000142	0.000411	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000141	0.000407	CcSEcCtD
Eletriptan—Nausea—Ethinyl Estradiol—osteoporosis	0.000141	0.000407	CcSEcCtD
Eletriptan—Insomnia—Estradiol—osteoporosis	0.00014	0.000404	CcSEcCtD
Eletriptan—Vomiting—Pamidronate—osteoporosis	0.000139	0.000404	CcSEcCtD
Eletriptan—Paraesthesia—Estradiol—osteoporosis	0.000139	0.000402	CcSEcCtD
Eletriptan—Asthenia—Conjugated Estrogens—osteoporosis	0.000138	0.000401	CcSEcCtD
Eletriptan—Rash—Pamidronate—osteoporosis	0.000138	0.000401	CcSEcCtD
Eletriptan—Dermatitis—Pamidronate—osteoporosis	0.000138	0.0004	CcSEcCtD
Eletriptan—Dyspnoea—Estradiol—osteoporosis	0.000138	0.000399	CcSEcCtD
Eletriptan—Headache—Pamidronate—osteoporosis	0.000137	0.000398	CcSEcCtD
Eletriptan—Somnolence—Estradiol—osteoporosis	0.000137	0.000398	CcSEcCtD
Eletriptan—Diarrhoea—Zoledronate—osteoporosis	0.000137	0.000397	CcSEcCtD
Eletriptan—Nausea—Risedronate—osteoporosis	0.000137	0.000397	CcSEcCtD
Eletriptan—Pruritus—Conjugated Estrogens—osteoporosis	0.000136	0.000395	CcSEcCtD
Eletriptan—Dyspepsia—Estradiol—osteoporosis	0.000136	0.000394	CcSEcCtD
Eletriptan—Decreased appetite—Estradiol—osteoporosis	0.000134	0.000389	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Estradiol—osteoporosis	0.000133	0.000386	CcSEcCtD
Eletriptan—Fatigue—Estradiol—osteoporosis	0.000133	0.000386	CcSEcCtD
Eletriptan—Dizziness—Zoledronate—osteoporosis	0.000132	0.000384	CcSEcCtD
Eletriptan—Constipation—Estradiol—osteoporosis	0.000132	0.000382	CcSEcCtD
Eletriptan—Pain—Estradiol—osteoporosis	0.000132	0.000382	CcSEcCtD
Eletriptan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000132	0.000382	CcSEcCtD
Eletriptan—Nausea—Pamidronate—osteoporosis	0.00013	0.000377	CcSEcCtD
Eletriptan—Dizziness—Conjugated Estrogens—osteoporosis	0.000128	0.000369	CcSEcCtD
Eletriptan—Vomiting—Zoledronate—osteoporosis	0.000127	0.000369	CcSEcCtD
Eletriptan—Feeling abnormal—Estradiol—osteoporosis	0.000127	0.000369	CcSEcCtD
Eletriptan—Rash—Zoledronate—osteoporosis	0.000126	0.000366	CcSEcCtD
Eletriptan—Gastrointestinal pain—Estradiol—osteoporosis	0.000126	0.000366	CcSEcCtD
Eletriptan—Dermatitis—Zoledronate—osteoporosis	0.000126	0.000366	CcSEcCtD
Eletriptan—Headache—Zoledronate—osteoporosis	0.000125	0.000364	CcSEcCtD
Eletriptan—Vomiting—Conjugated Estrogens—osteoporosis	0.000123	0.000355	CcSEcCtD
Eletriptan—Urticaria—Estradiol—osteoporosis	0.000123	0.000355	CcSEcCtD
Eletriptan—Abdominal pain—Estradiol—osteoporosis	0.000122	0.000354	CcSEcCtD
Eletriptan—Body temperature increased—Estradiol—osteoporosis	0.000122	0.000354	CcSEcCtD
Eletriptan—Rash—Conjugated Estrogens—osteoporosis	0.000122	0.000352	CcSEcCtD
Eletriptan—Dermatitis—Conjugated Estrogens—osteoporosis	0.000121	0.000352	CcSEcCtD
Eletriptan—Headache—Conjugated Estrogens—osteoporosis	0.000121	0.00035	CcSEcCtD
Eletriptan—Nausea—Zoledronate—osteoporosis	0.000119	0.000345	CcSEcCtD
Eletriptan—Nausea—Conjugated Estrogens—osteoporosis	0.000115	0.000332	CcSEcCtD
Eletriptan—Hypersensitivity—Estradiol—osteoporosis	0.000114	0.000329	CcSEcCtD
Eletriptan—Asthenia—Estradiol—osteoporosis	0.000111	0.000321	CcSEcCtD
Eletriptan—Pruritus—Estradiol—osteoporosis	0.000109	0.000316	CcSEcCtD
Eletriptan—Diarrhoea—Estradiol—osteoporosis	0.000106	0.000306	CcSEcCtD
Eletriptan—Dizziness—Estradiol—osteoporosis	0.000102	0.000296	CcSEcCtD
Eletriptan—Vomiting—Estradiol—osteoporosis	9.81e-05	0.000284	CcSEcCtD
Eletriptan—Rash—Estradiol—osteoporosis	9.73e-05	0.000282	CcSEcCtD
Eletriptan—Dermatitis—Estradiol—osteoporosis	9.72e-05	0.000282	CcSEcCtD
Eletriptan—Headache—Estradiol—osteoporosis	9.67e-05	0.00028	CcSEcCtD
Eletriptan—Nausea—Estradiol—osteoporosis	9.17e-05	0.000266	CcSEcCtD
Eletriptan—CYP2C19—Metabolism—MGLL—osteoporosis	2.74e-05	0.000425	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTH—osteoporosis	2.72e-05	0.000422	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—FGB—osteoporosis	2.72e-05	0.000422	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SPP1—osteoporosis	2.7e-05	0.000419	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.69e-05	0.000418	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CALCA—osteoporosis	2.67e-05	0.000416	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MGLL—osteoporosis	2.67e-05	0.000415	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RAP1A—osteoporosis	2.67e-05	0.000415	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CALCA—osteoporosis	2.66e-05	0.000413	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CNR2—osteoporosis	2.65e-05	0.000412	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—ADCY5—osteoporosis	2.63e-05	0.000409	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PSMA2—osteoporosis	2.62e-05	0.000408	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PSMA5—osteoporosis	2.62e-05	0.000408	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—POMC—osteoporosis	2.61e-05	0.000405	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NFATC1—osteoporosis	2.6e-05	0.000405	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CALCA—osteoporosis	2.6e-05	0.000404	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—POMC—osteoporosis	2.59e-05	0.000403	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IRS2—osteoporosis	2.59e-05	0.000402	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—DKK1—osteoporosis	2.58e-05	0.000402	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—OXCT1—osteoporosis	2.58e-05	0.000401	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CA2—osteoporosis	2.58e-05	0.000401	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.58e-05	0.000401	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—OXCT1—osteoporosis	2.56e-05	0.000398	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CA2—osteoporosis	2.56e-05	0.000398	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—POMC—osteoporosis	2.54e-05	0.000394	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—LEP—osteoporosis	2.53e-05	0.000393	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MGLL—osteoporosis	2.52e-05	0.000391	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MGLL—osteoporosis	2.49e-05	0.000388	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ENO1—osteoporosis	2.49e-05	0.000388	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—WNT1—osteoporosis	2.49e-05	0.000387	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PSMA2—osteoporosis	2.46e-05	0.000382	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PSMA5—osteoporosis	2.46e-05	0.000382	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CALCA—osteoporosis	2.44e-05	0.00038	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IRS2—osteoporosis	2.44e-05	0.000379	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KL—osteoporosis	2.43e-05	0.000378	CbGpPWpGaD
Eletriptan—CYP3A4—Biological oxidations—POMC—osteoporosis	2.43e-05	0.000377	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FGA—osteoporosis	2.42e-05	0.000376	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—ESR1—osteoporosis	2.42e-05	0.000376	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KL—osteoporosis	2.41e-05	0.000375	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—LEP—osteoporosis	2.39e-05	0.000371	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—ADCY5—osteoporosis	2.39e-05	0.000371	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—POMC—osteoporosis	2.38e-05	0.000371	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—POMC—osteoporosis	2.37e-05	0.000368	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KL—osteoporosis	2.36e-05	0.000367	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ENO1—osteoporosis	2.36e-05	0.000366	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—POMC—osteoporosis	2.35e-05	0.000366	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.35e-05	0.000366	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—IDH2—osteoporosis	2.33e-05	0.000362	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PSMA5—osteoporosis	2.32e-05	0.000361	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PSMA2—osteoporosis	2.32e-05	0.000361	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6R—osteoporosis	2.31e-05	0.000359	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—POMC—osteoporosis	2.3e-05	0.000358	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6R—osteoporosis	2.3e-05	0.000357	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—FDPS—osteoporosis	2.29e-05	0.000356	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PKM—osteoporosis	2.29e-05	0.000356	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ESR1—osteoporosis	2.28e-05	0.000354	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—IDH2—osteoporosis	2.27e-05	0.000353	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IRS1—osteoporosis	2.26e-05	0.000351	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTHLH—osteoporosis	2.25e-05	0.00035	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—BMP2—osteoporosis	2.25e-05	0.00035	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6R—osteoporosis	2.25e-05	0.000349	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KL—osteoporosis	2.22e-05	0.000345	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FGB—osteoporosis	2.2e-05	0.000342	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.19e-05	0.00034	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—POMC—osteoporosis	2.17e-05	0.000338	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PGLS—osteoporosis	2.17e-05	0.000337	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GPD2—osteoporosis	2.17e-05	0.000337	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—POMC—osteoporosis	2.16e-05	0.000336	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—IDH2—osteoporosis	2.14e-05	0.000333	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP27A1—osteoporosis	2.13e-05	0.000332	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IRS1—osteoporosis	2.13e-05	0.000331	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ACP5—osteoporosis	2.13e-05	0.000331	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PSMA2—osteoporosis	2.13e-05	0.000331	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PSMA5—osteoporosis	2.13e-05	0.000331	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—IDH2—osteoporosis	2.12e-05	0.00033	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6R—osteoporosis	2.12e-05	0.00033	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6R—osteoporosis	2.11e-05	0.000328	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.1e-05	0.000327	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.09e-05	0.000326	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IGF1—osteoporosis	2.09e-05	0.000325	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.09e-05	0.000325	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ACP5—osteoporosis	2.08e-05	0.000323	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—POMC—osteoporosis	2.05e-05	0.000319	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.01e-05	0.000313	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6R—osteoporosis	2e-05	0.000311	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.99e-05	0.00031	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CYP19A1—osteoporosis	1.99e-05	0.00031	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PNP—osteoporosis	1.99e-05	0.000309	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ATIC—osteoporosis	1.99e-05	0.000309	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CALCA—osteoporosis	1.98e-05	0.000308	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—TPI1—osteoporosis	1.98e-05	0.000307	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IGF1—osteoporosis	1.97e-05	0.000307	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ACP5—osteoporosis	1.96e-05	0.000304	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.96e-05	0.000304	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.95e-05	0.000303	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ACP5—osteoporosis	1.94e-05	0.000302	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—POMC—osteoporosis	1.93e-05	0.0003	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—TPI1—osteoporosis	1.93e-05	0.0003	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.92e-05	0.000298	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ADCY5—osteoporosis	1.9e-05	0.000296	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ADCY5—osteoporosis	1.89e-05	0.000294	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CYP19A1—osteoporosis	1.88e-05	0.000293	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—P4HB—osteoporosis	1.86e-05	0.000289	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ADCY5—osteoporosis	1.85e-05	0.000288	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SPP1—osteoporosis	1.84e-05	0.000286	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SPP1—osteoporosis	1.83e-05	0.000284	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GAPDH—osteoporosis	1.83e-05	0.000284	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—TPI1—osteoporosis	1.82e-05	0.000283	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—P4HB—osteoporosis	1.82e-05	0.000282	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—TPI1—osteoporosis	1.8e-05	0.00028	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KL—osteoporosis	1.8e-05	0.00028	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SPP1—osteoporosis	1.79e-05	0.000278	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GAPDH—osteoporosis	1.78e-05	0.000277	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—RAP1A—osteoporosis	1.78e-05	0.000276	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—POMC—osteoporosis	1.76e-05	0.000273	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ADCY5—osteoporosis	1.74e-05	0.00027	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—RAP1A—osteoporosis	1.74e-05	0.00027	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6R—osteoporosis	1.71e-05	0.000266	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—P4HB—osteoporosis	1.71e-05	0.000266	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—P4HB—osteoporosis	1.7e-05	0.000264	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CA2—osteoporosis	1.69e-05	0.000262	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—OXCT1—osteoporosis	1.69e-05	0.000262	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SPP1—osteoporosis	1.68e-05	0.000261	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GAPDH—osteoporosis	1.68e-05	0.000261	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GAPDH—osteoporosis	1.66e-05	0.000259	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IRS2—osteoporosis	1.66e-05	0.000259	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IRS2—osteoporosis	1.65e-05	0.000257	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MGLL—osteoporosis	1.65e-05	0.000256	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—RAP1A—osteoporosis	1.64e-05	0.000254	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—LEP—osteoporosis	1.63e-05	0.000253	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ADCY5—osteoporosis	1.63e-05	0.000253	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GPX1—osteoporosis	1.62e-05	0.000252	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—RAP1A—osteoporosis	1.62e-05	0.000252	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.62e-05	0.000252	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—LEP—osteoporosis	1.62e-05	0.000252	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL6—osteoporosis	1.6e-05	0.000249	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—LEP—osteoporosis	1.58e-05	0.000246	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ESR1—osteoporosis	1.56e-05	0.000242	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.55e-05	0.000241	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.54e-05	0.00024	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ADCY5—osteoporosis	1.54e-05	0.000239	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GPX1—osteoporosis	1.53e-05	0.000239	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IRS2—osteoporosis	1.52e-05	0.000236	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.51e-05	0.000235	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL6—osteoporosis	1.51e-05	0.000234	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—MTHFR—osteoporosis	1.5e-05	0.000233	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—LEP—osteoporosis	1.49e-05	0.000231	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IRS1—osteoporosis	1.45e-05	0.000226	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.44e-05	0.000224	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ENO1—osteoporosis	1.44e-05	0.000223	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.42e-05	0.000221	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PSMA2—osteoporosis	1.42e-05	0.00022	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PSMA5—osteoporosis	1.42e-05	0.00022	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—MTHFR—osteoporosis	1.42e-05	0.00022	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.41e-05	0.00022	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.41e-05	0.00022	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.41e-05	0.000219	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ENO1—osteoporosis	1.4e-05	0.000218	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—POMC—osteoporosis	1.4e-05	0.000218	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—IDH2—osteoporosis	1.4e-05	0.000217	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—POMC—osteoporosis	1.39e-05	0.000216	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PSMA2—osteoporosis	1.38e-05	0.000215	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PSMA5—osteoporosis	1.38e-05	0.000215	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6R—osteoporosis	1.36e-05	0.000212	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.36e-05	0.000212	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—POMC—osteoporosis	1.36e-05	0.000212	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.36e-05	0.000211	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IGF1—osteoporosis	1.35e-05	0.000209	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.34e-05	0.000208	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.33e-05	0.000206	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.33e-05	0.000206	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ENO1—osteoporosis	1.32e-05	0.000205	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.32e-05	0.000204	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ENO1—osteoporosis	1.31e-05	0.000204	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.31e-05	0.000204	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PSMA2—osteoporosis	1.3e-05	0.000202	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PSMA5—osteoporosis	1.3e-05	0.000202	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PSMA5—osteoporosis	1.29e-05	0.000201	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PSMA2—osteoporosis	1.29e-05	0.000201	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ACP5—osteoporosis	1.28e-05	0.000199	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—POMC—osteoporosis	1.28e-05	0.000199	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MYC—osteoporosis	1.26e-05	0.000195	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TGFB1—osteoporosis	1.25e-05	0.000195	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.25e-05	0.000194	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.23e-05	0.000192	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.23e-05	0.000191	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—LEP—osteoporosis	1.21e-05	0.000188	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—POMC—osteoporosis	1.2e-05	0.000186	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TPI1—osteoporosis	1.19e-05	0.000185	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MYC—osteoporosis	1.19e-05	0.000184	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TGFB1—osteoporosis	1.18e-05	0.000184	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.15e-05	0.000179	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.15e-05	0.000179	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—POMC—osteoporosis	1.13e-05	0.000176	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP19A1—osteoporosis	1.12e-05	0.000174	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—P4HB—osteoporosis	1.12e-05	0.000174	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GAPDH—osteoporosis	1.1e-05	0.000171	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.08e-05	0.000167	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—RAP1A—osteoporosis	1.07e-05	0.000166	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.06e-05	0.000164	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.05e-05	0.000163	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—POMC—osteoporosis	1.04e-05	0.000161	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6—osteoporosis	1.03e-05	0.00016	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.02e-05	0.000159	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.01e-05	0.000157	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6—osteoporosis	1e-05	0.000156	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF1—osteoporosis	9.97e-06	0.000155	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—osteoporosis	9.45e-06	0.000147	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—osteoporosis	9.41e-06	0.000146	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ADCY5—osteoporosis	9.39e-06	0.000146	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GPX1—osteoporosis	9.36e-06	0.000145	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ADCY5—osteoporosis	9.16e-06	0.000142	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GPX1—osteoporosis	9.13e-06	0.000142	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—osteoporosis	8.91e-06	0.000139	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ENO1—osteoporosis	8.64e-06	0.000134	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ADCY5—osteoporosis	8.63e-06	0.000134	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—MTHFR—osteoporosis	8.63e-06	0.000134	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GPX1—osteoporosis	8.6e-06	0.000134	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ADCY5—osteoporosis	8.56e-06	0.000133	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GPX1—osteoporosis	8.53e-06	0.000133	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PSMA5—osteoporosis	8.52e-06	0.000132	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PSMA2—osteoporosis	8.52e-06	0.000132	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MTHFR—osteoporosis	8.43e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MYC—osteoporosis	8.09e-06	0.000126	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TGFB1—osteoporosis	8.07e-06	0.000125	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MYC—osteoporosis	8.04e-06	0.000125	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TGFB1—osteoporosis	8.02e-06	0.000125	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MTHFR—osteoporosis	7.94e-06	0.000123	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MTHFR—osteoporosis	7.87e-06	0.000122	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MYC—osteoporosis	7.87e-06	0.000122	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TGFB1—osteoporosis	7.85e-06	0.000122	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—osteoporosis	7.63e-06	0.000119	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MYC—osteoporosis	7.39e-06	0.000115	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TGFB1—osteoporosis	7.37e-06	0.000115	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.91e-06	0.000107	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—POMC—osteoporosis	6.9e-06	0.000107	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—POMC—osteoporosis	6.74e-06	0.000105	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—POMC—osteoporosis	6.35e-06	9.87e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—POMC—osteoporosis	6.3e-06	9.79e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—osteoporosis	6.08e-06	9.45e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—osteoporosis	6.04e-06	9.39e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MYC—osteoporosis	5.99e-06	9.32e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.98e-06	9.3e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—osteoporosis	5.91e-06	9.19e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ADCY5—osteoporosis	5.65e-06	8.78e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GPX1—osteoporosis	5.63e-06	8.75e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—osteoporosis	5.56e-06	8.64e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MTHFR—osteoporosis	5.19e-06	8.07e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—osteoporosis	4.51e-06	7e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—POMC—osteoporosis	4.15e-06	6.46e-05	CbGpPWpGaD
